Benitec Biopharma Inc. BNTC
$11.05
▲ +1.18% 24H
About
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on developing novel genetic medicines for chronic and life-threatening conditions. It employs its proprietary Silence and Replace platform, which combines DNA-directed RNA interference with gene therapy to enable sustained silencing of disease-cau…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees19
TickerBNTC
Statistics
Market Cap$379.6M
Revenue (TTM)—
Net Income-$37.9M
Net Margin—
EPS$-1.05
P/E-10.66
P/S—
P/B2.07
EV/EBITDA-3.72
ROE-29.6%
Dividend Yield—
Price$11.05
Data: Twelve Data · Revenue = mcap / P/S